SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001127602-21-010883
Filing Date
2021-03-16
Accepted
2021-03-16 18:50:57
Documents
1
Period of Report
2018-03-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4a.html 4/A  
1 PRIMARY DOCUMENT form4a.xml 4/A 4936
  Complete submission text file 0001127602-21-010883.txt   6391
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Issuer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O UNITED THERAPEUTICS CORP 1040 SPRING STREET SILVER SPRING MD 20910
Business Address
BENKOWITZ MICHAEL (Reporting) CIK: 0001673232 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-26301 | Film No.: 21747640